Advertisement

Topics

Bayer AG (FRA:BAYN) Given a 120.00 Price Target by Independent Research GmbH Analysts

04:53 EDT 29 Jul 2017 | Topix

The brokerage currently has a "neutral" rating on the healthcare company's stock. Several other equities analysts have also issued reports on the stock.

Original Article: Bayer AG (FRA:BAYN) Given a 120.00 Price Target by Independent Research GmbH Analysts

NEXT ARTICLE

More From BioPortfolio on "Bayer AG (FRA:BAYN) Given a 120.00 Price Target by Independent Research GmbH Analysts"

Quick Search
Advertisement
 

Relevant Topic

Healthcare
Health care (or healthcare) is the diagnosis, treatment, and prevention of disease, illness, injury, and other physical and mental impairments in humans. Health care is delivered by practitioners in medicine, chiropractic, dentistry, nursing, pharmacy, a...